Delivery Order SPE2DB24D3015-SPE2DB25FGAVY
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52 with completion scheduled for September 23, 2025, represents a non-competitive award issued under an existing contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,385.52 to supply Orgovyx 120 mg tablets (30-count units) with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside contract features firm fixed-price pricing and reflects the DLA's ongoing pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,385.52 in firm fixed price pharmaceutical supplies, specifically 30-count boxes of Orgovyx 120 mg tablets. This non-competitive delivery order, issued on August 5, 2025, with completion targeted for August 26, 2025, will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item procurement under a larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This contract, valued at $4,156.56 with a firm fixed price structure, represents a non-set-aside competitive award with an ultimate completion date of August 22, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Orgovyx 120 mg tablets (quantity: 30 units) under a firm fixed price contract. The award, valued at $16,626.24, has an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This competitively awarded, non-set-aside delivery order represents a single procurement action against AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,771.04 with firm fixed pricing and is scheduled for completion by September 9, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Orgovyx 120 mg tablets (30 count) with a ceiling value of $2,771.04. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is set to conclude on September 15, 2025, and performance will occur at the contractor's Conshohocken facility....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a contract ceiling value of $1,385.52. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery...
- The Defense Logistics Agency awarded a Delivery Order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52, is scheduled for completion by August 14, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The contract was competitively awarded without set-aside provisions, reflecting AmerisourceBergen's capability to meet federal...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAVYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 per unit, with a ceiling value of $1,385.52. This firm fixed-price delivery order, with an ultimate completion date of September 25, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters and primary distribution hub for federal pharmaceutical procurement operations. This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive $999.99 billion Pharmaceutical Prime Vendor Global Program IDC with DLA Troop Support Medical (contract designation SPE2DX), which runs through December 2026 and enables the company to supply a broad range of pharmaceutical products and medical supplies to military and federal healthcare systems worldwide. As a leading pharmaceutical distributor, AmerisourceBergen serves critical federal medical procurement needs through competitively awarded contracts covering diverse therapeutic domains including specialty medications, vaccines, and medical devices. The DLA's Pharmaceutical Prime Vendor program supports military healthcare delivery through flexible contract vehicles that allow efficient fulfillment of recurring pharmaceutical supply requirements across Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/4/25 |